• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/25

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

25 Cards in this Set

  • Front
  • Back
MOA Benzos
Inhibitory at postsynaptic GABAa receptors in amgdala
Non linear kinetics
Cleared by hepatic metabolism
Do not change hepatic drug metabolizing activity with cts. use
Barbituates
Bind to multiple isoforms of GABAa receptors (different site than benzos)
Increase duration of GABA gated chloride channel openings
Facilitate actions of GABA at multiple sites in CNA
Less selective than benzos
Depress actions of excitatory NT glutamic acid
Slow metabolism (except thiobarbiturates)
May increase hepative metabolism (of self and other drugs)-- Especially PB and meprobamate
Newer Hypnotics
Selectively bind only a1 subunits of GABAa
Don't change hepatic drug metabolizing activity with cts. use
Metabolized to inactive form
Rapid onset, modest day after psychomotor depression with few amnestic effects
Preferred over older drugs (chloral hydrate, secobarbital, pentobarbital)
Alprazolam
Undergoes a-hydroxylation
-Creates short half life metabolite
Chlordiazepoxide
Long acting and self tapering because of active metabolites; prodrug
Clorazepate
Converted to active metabolite Nordiazepam (long half life) with rapid absorption
Diazepam
More rapid absorption
Long half life
Estazolam
Right to Glucuronidation
Flurazepam
Short half life
Lorazepam
Intermediate/Short half life
Right to Glucuronidation
Midazolam
Short half life
Oxazepam
Intermediate/short half life
Right to Glucuronidation
Quazepam
Long half life
Temazepam
Intermediate half life
Triazolam
Extremely rapid absorption
Rapid onset of CNS effects
Short elimination
Short half life
Pentobarbital
Shorter elimination half life
Secobarbital
Shorter elimination half life
Flumazenil
Benzo antagonist
High affinity for benzo binding site on GABAa receptors (competitive antagonist)
Blocks actions of benzos, zolpidem, zaleplon, eszopiclone
Acts rapidly with a short half life (due to rapid hepatic clearance)
Synthetic benzo derivative
Eszopiclone
Absorbed rapidly into the blood
Rapid onset of CNS effects
Similar to benzos
Half life= 6hrs
Zaleplon
Similiar to benzos
Absorbed rapidly into the blood
Rapid onset of CNS effects
More minimal tolerance
Acts rapidly
Short half life (1hr)
Zolpidem
Biphasic release
Similar to benzos
Absorbed rapidly into the blood
Rapid onset of CNS effects
Half life= 1.5-3.5hrs
Ramelteon
Agonist at MT1 and MT2 (Melatonin receptors)
No direct effects on GABAergic NT in CNS
Reduces latency of persistent sleep
Rapidly absorbed
No effects on sleeep architecture, no rebound insomnia or significant withdrawal symptoms
Buspirone
Slow onset anxiolytic agent
Doesn't interact directly with GABAergic systems
Partial agonist at brain 5-HT1a receptors
Affinity for D2 receptors
Meprobamate
Formation of gastric bezoars occurs with intoxication
Little impairment of locomotor activity
Can cause widespread depression of CNS
Mostly metabolized in liver
Chloral hydrate
Metabolized rapidly to active compound in liver
Exhibits barbiturate like effects on GABAa receptor channels